Comparative study of estrogen receptor α, β mRNA expressions of endometriosis and normal endometrium in women and analysis of potential synthetic anti-estrogens in silico

Comparative study of estrogen receptor α, β mRNA expressions of endometriosis and normal endometrium in women and analysis of potential synthetic anti-estrogens in silico All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. Published: 28 November 2018 Endometriosis is a multifactorial disease in which genetic and environmental factors interact causing its pathogenesis. The aim of this study was to investigate the expression pattern of estrogen receptor α (ERα) and β (ERβ) in endometriosis patients compared to normal endometrioum (n=18) as a control by using Quantitative Real Time PCR method. Moreover, we also measured serum estradiol levels of endometriosis patients in the proliferation phase of the menstrual cycle using the enzyme-linked immunosorbent assay method. The mRNA expression of ERβ was significantly higher in the endometriosis group compared to control, and the result of t-test showed that were significantly different (P<0.05). Overexpression of ERβ in endometriosis was likely to have other significant important impacts in the pathology of endometriosis that allowed ERβ to stimulate prostaglandin production in endometriosis tissue and cells. Estradiol content did not correlate with the ERα expression, and it is weakly correlated with ERβ mRNA expression. Molecular docking analysis showed that ERα and ERβ have different binding interactions with synthetic antiestrogens, whereas the best inhibitor was Ral2 to ERα and Aco1 to ERβ. Thus, both inhibitors could be used as leads in further investigation of ERα, ERβ inhibitory activities in vitro and in vivo. Downloads Bouquet De Joliniere J, Ayoubi JM, Gianaroli L, et al. Endometriosis: a new cellular and molecular genetic approach for understanding the pathogenesis and evolutivity. Front Surg 2014;1:16. Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am 2012;39:535-49. Harada T. Dysmenorrhea and endometriosis in young women. Yonago Acta Med 2013;56:81-4. Bulun SE, Cheng YH, Pavone ME, et al. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med 2010;28:36-43. Dun EC, Taylor RN, Wieser F. Advances in the genetics of endometriosis. Genome Med 2010;2:75. Bulun SE, Monsavais D, Pavone ME, et al. Role of estrogen receptor-beta in endometriosis. Semin Reprod Med 2012;30:39-45. Bloski T, Pierson R. Endometriosis and Chronic Pelvic Pain: Unraveling the Mystery Behind this Complex Condition. Nurs Womens Health 2008;12:382-95. Silva CP, Lima DL, Schneider RJ, et al. Development of ELISA methodologies for the direct determination of 17beta-estradiol and 17alpha-ethinylestradiol in complex aqueous matrices. J Environ Manage 2013;124:121-7. Renner SP, Strick R, Oppelt P, et al. Evaluation of clinical parameters and estrogen receptor alpha gene polymorphisms for patients with endometriosis. Reproduction 2006;131:153-61. Estradiol ELISA DRG instruments GmbH; 2010. Available from: http://www.drg-diagnostics.de/44-1-DRG+ELISAs.html?ItemPage=4. Roche High Pure RNA isolation Kit; 2011. Available from: https://lifescience.roche.com/documents/High-Pure-RNA-Isolation-Kit.pdf R Roche Transcriptor first strand cDNA synthesis Kit; 2010. Available from: http://www.dynebio.co.kr/yc/shop/dw.php?fn=1402000958%2F04379012001_cDNA.pdf Applied Biosystems TaqMan Gene expression Assays; 2010. Available from: https://tools.thermofisher.com/content/sfs/manuals/cms_041280.pdf Berman HM, Westbrook J, Feng Z, et al. The Protein Data Bank. Nucleic Acids Res 2000;28:235-42. Gao YD, Huang JF. [An extension strategy of Discovery Studio 2.0 for non-bonded interaction energy automatic calculation at the residue level]. Dongwuxue Yanjiu 2011;32:262-6. Kim S, Thiessen PA, Bolton EE, et al. PubChem Substance and Compound databases. Nucleic Acids Res 2016;44:D1202-13. James T, Hsieh ML, Knipling L, et al. Determining the Architecture of a Protein-DNA Complex by Combining FeBABE Cleavage Analyses, 3-D Printed Structures, and the ICM Molsoft Program. Methods Mol Biol 2015;1334:29-40. Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010;31:455-61. Reed BG, Carr BR, The Normal Menstrual Cycle and the Control of Ovulation., Eds. South Dartmouth, MA; 2000. Muchtaridi M, Syahidah HN, Subarnas A, et al. Molecular Docking and 3D-Pharmacophore Modeling to Study the Interactions of Chalcone Derivatives with Estrogen Receptor Alpha. Pharmaceuticals (Basel) 2017;10. Seeliger D, de Groot BL. Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des 2010;24:417-22. Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 1995;8:127-34. Vercellini P, Vigano P, Somigliana E, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 2014;10:261-75. Bulun SE, Lin Z, Imir G, et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 2005;57:359-83. Cui J, Shen Y, Li R. Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol Med 2013;19:197-209. Bombail V, MacPherson S, Critchley HO, et al. Estrogen receptor related beta is expressed in human endometrium throughout the normal menstrual cycle. Hum Reprod 2008;23:2782-90. Rahmioglu N, Montgomery GW, Zondervan KT. Genetics of endometriosis. Womens Health (Lond) 2015;11:577-86. Supporting Agencies How to Cite PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.